Fast-scan cyclic voltammetry to assess dopamine release in ex vivo mouse brain slices

By Katherine Brimblecombe, PhD and Stephanie Cragg, PhD
View Published Protocol

Output Details

Description
This protocol is to assess whether a drug changes the dopamine concentration released following a single pulse (1p) electrical stimulation.
Identifier (DOI)
10.17504/protocols.io.4r3l271zxg1y/v1
Tags
  • Dopamine
  • Dopaminergic neurons
  • Ex Vivo
  • Mouse
  • Voltammetry
Team
Team Cragg
Program
Collaborative Research Network
Theme
Circuitry and Brain-Body Interactions

Meet the Authors

Related Research

Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson’s

This data show that LTCC function in DA axons, and isradipine effect, are locally governed and suggest they vary in a manner that in turn might impact on, or reflect, the cellular stress that leads to parkinsonian degeneration.

View Article

Postsynaptic adaptations in direct pathway muscarinic M4-receptor signaling follow the temporal and regional pattern of dopaminergic degeneration

Imbalances in dorsal striatum output in Parkinson's disease are driven by dopamine loss and disrupted acetylcholine signaling. These changes occur in response to dopamine loss, affecting M4 receptors in striatal neurons, crucial for PD progression.

View Article

Histology Fushiki et al 2024

Histology protocol for Fushiki et al 2024 , to quantify Th+ cells and visualize the dorsal-tier or ventral-tier of SNc DANs.

View Protocol
View More Outputs